Clarification
With reference to the news item appearing in certain section of media on January 23, 2014 mentioning "Jyothy Labs' Jt MD plans VC investments", Jyothy Laboratories Ltd has submitted to BSE the letter dated January 23, 2014 from Mr. Ullas Kamath, Joint Managing Director of the Company to the Executive Editor of Business Standard, Mumbai. In this letter, Mr. Kamath has clearly stated that the captioned news item is completely baseless and untrue. Board to consider Interim Dividend
Jyothy Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 28, 2014, inter alia, for considering the Un-Audited financial results of the Company for the 3rd Quarter ended December 31, 2013 and also to consider declaration of interim dividend for the financial year 2013-14. Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Jyothy Laboratories Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
IL & FS Trust Company Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
M P Ramachandran has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Sahyadri Agencies Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
IDBI Trusteeship Services Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 Outcome of Preferential Allotment Committee Meeting
Jyothy Laboratories Ltd has informed BSE that in pursuance to the Shareholders approval at the EGM of the Company held on November 19, 2013 and the In-Principle Approval granted by the Stock Exchanges, the Preferential Allotment Committee of the Board of Directors of the Company at its meeting held on December 03, 2013, has allotted 1,50,00,000 (One Crore Fifty Lacs) equity shares of the Company of Re. 1/- each to Sahyadri Agencies Limited on Preferential... Disclosure of Voting results of AGM (Clause 35A)
Jyothy Laboratories Ltd has informed BSE regarding the details of Voting results at the Extra Ordinary General Meeting (EGM) of the Company held on November 19, 2013, under Clause 35A. EGM on Nov 19, 2013
Jyothy Laboratories Ltd has informed BSE that the Extra Ordinary General Meeting (EGM) of the Company will be held on November 19, 2013.